On Thursday, IAC/InterActiveCorp (NASDAQ:IACI)’s shares declined -3.34% to $71.15.
IAC (IACI) declared that Gary Swidler will join The Match Group as Chief Financial Officer. Mr. Swidler is being designated to this newly created group position in anticipation of The Match Group’s formerly declared initial public offering (IPO).
Mr. Swidler joins The Match Group from Bank of America Merrill Lynch. Mr. Swidler has been an executive at Bank of America Merrill Lynch and its predecessors for nearly 18 years in various capacities. Most recently, he served as a Managing Director where he led the Financial Institutions Investment Banking Group.
IAC/InterActiveCorp operates as a media and Internet company in the United States and internationally. It operates through four segments: The Match Group, Search & Applications, Media, and eCommerce. The Match Group segment provides subscription-based and ad-supported online personals services through its Websites and applications.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI)’s shares dropped -3.05% to $6.36.
BioDelivery Sciences International, Inc. (BDSI) declared the approval by the U.S. Food and Drug Administration (FDA) of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS® (fentanyl buccal soluble film) CII for the administration of breakthrough pain in patients with cancer who are opioid tolerant. The new formulation was presented to address formerly declared appearance-related changes.
Early this year, BDSI declared that it reached an assignment and revenue sharing agreement with its partner for ONSOLIS, Meda Pharmaceuticals, to return the marketing authorization back to BDSI and the right to seek marketing authorizations for ONSOLIS in the United States, Canada and Mexico. Meda retains the rights to ONSOLIS outside the U.S., where it is marketed in the E.U. as BREAKYL. ONSOLIS is separately licensed by BDSI in Taiwan and South Korea.
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain administration and addiction. The company provides its products based on its patented BioErodible MucoAdhesive (BEMA) drug delivery technology, which comprises of a small, bi-layered erodible polymer film for application to the buccal mucosa.
At the end of Thursday’s trade, Owens-Illinois Inc (NYSE:OI)‘s shares dipped -2.90% to $21.09.
Owens-Illinois, Inc. (OI) declared that Owens-Brockway Glass Container Inc. (“OBGC”), an indirect wholly owned partner of OI Inc., intends to offer, subject to market and other conditions, a total of $1.0 billion aggregate principal amount of senior notes due 2023 and senior notes due 2025 in a private offering to eligible purchasers under Rule 144A and Regulation S of the Securities Act of 1933, as amended (the “Securities Act”). OBGC`s obligations under the senior notes will be guaranteed on a joint and several basis by Owens-Illinois Group, Inc. (“OI Group”), a direct wholly owned partner of OI Inc. and an indirect parent of OBGC, and the domestic auxiliaries of OI Group that are guarantors under OI Group`s credit agreement.
OBGC anticipates to use the net proceeds from the private offering to fund, in part, its formerly declared acquisition of the food and beverage glass containers business of Vitro, S.A.B. de C.V. and its auxiliaries as conducted in the United States, Mexico and Bolivia (the “Vitro Acquisition”) and to pay related fees and expenses. The private offering of senior notes will be consummated preceding to the consummation of the Vitro Acquisition. Conpresently with the closing of the private offering, the gross proceeds from the sale of the senior notes will be deposited into an escrow account until the consummation of the Vitro Acquisition.
Owens-Illinois, Inc., through its auxiliaries, manufactures and sells glass container products to food and beverage manufacturers primarily in Europe, North America, South America, and the Asia Pacific. It produces glass containers for alcoholic beverages, counting beer, flavored malt beverages, spirits, and wine. The company is also involved in the production of glass packaging for various food items, soft drinks, teas, juices, and pharmaceuticals. It offers glass containers in a range of sizes, shapes, and colors.
VASCO Data Security International, Inc. (NASDAQ:VDSI), ended its Thursday’s trading session with -4.70% loss, and closed at $17.63.
VASCO Data Security International, Inc. (VDSI), a global leader in authentication, electronic signatures, and identity administration, declared that Jibun Bank Corporation has implemented VASCO’s DIGIPASS for Apps and VACMAN Controller to enhance security for online and mobile banking customers.
Jibun Bank was founded in 2008 as a joint venture between Japanese communications company KDDI Corporation and Bank of Tokyo-Mitsubishi UFJ. Jibun Bank is a direct-only bank with the aims of being a “personal bank for each individual customer,” and providing quality financial services with high convenience and security that take full advantage of mobile phones.
VASCO Data Security International, Inc., together with its auxiliaries, designs, develops, markets, and supports hardware and software security systems that manage and secure access to information assets worldwide. The company offers VACMAN Controller, a host system software authentication platform that combines technologies in one platform; IDENTIKEY Authentication Server that adds server functionality to the VACMAN core authentication platform; DIGIPASS as a Service, a cloud-based authentication service primarily for enterprise customers; and MYDIGIPASS solutions for end user authentication in the cloud.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
